Single dose escalation trial of RTU 1096 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 26 May 2015
At a glance
- Drugs RTU 1096 (Primary)
- Indications Atopic dermatitis; Psoriasis
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors R-Tech Ueno
- 26 May 2015 Status changed from recruiting to completed according to an R-Tech Uno media release.
- 25 May 2015 Results published in an R-Tech Uno Media Release.
- 23 Oct 2014 New trial record